What stage does CentreStone Ventures invest at?

CentreStone Ventures invests at the Pre-Seed, Seed, Series A stages.

What is CentreStone Ventures's typical check size?

CentreStone Ventures typically writes checks of $182.5K – $1.8M.

What sectors does CentreStone Ventures focus on?

CentreStone Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is CentreStone Ventures located?

CentreStone Ventures is headquartered in Winnipeg, CA.

CentreStone Ventures

Venture capital

Winnipeg · Pre-Seed–Series A · 3 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

CentreStone Ventures backs early-stage life sciences companies developing therapeutics, medical devices, diagnostics and novel drug delivery methods. It targets companies addressing large markets with unmet clinical needs, built on strong intellectual property and a mix of entrepreneurial and technical talent with the potential to lead their markets. Based in Winnipeg at the geographic centre of North America, the firm sources opportunities from research centres across the continent, with particular focus on Western Canada and the U.S. Midwest. Beyond capital, CentreStone partners with scientific entrepreneurs, offering structure, support and guidance to build a foundation for commercial development.

Invests inBiotech Digital Health Healthtech Medical Devices Canada North America United States

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

Check

$182.5K – $1.8M

Winnipeg, Manitoba, CA

Instruments

Equity

Founded

2004

AUM

$18.3M

Tracked investments

Team · 3 people

from the firm's website & public directories

Albert D. Friesen· Dr.

Holds a Ph.D. in Protein Chemistry from the University of Manitoba and was the first employee and President of the Winnipeg Rh Institute, overseeing the development of WinRho. He has founded several health industry companies including Novopharm Biotech (now Viventia Biotech), Genesys Pharma, Miraculins, Diamedica and Medicure, and has managed development of numerous pharmaceutical candidates.

a•••@centrestoneventures.comreveal

James Kinley· CA

A Chartered Accountant responsible for the financial operations and reporting of GVI and its client companies. He previously managed financial reporting at Manitoba Telecom Services and was an Audit Senior at Ernst & Young.

Marcus Enns· Vice President, Corporate Affairs

Holds a Bachelor of Commerce (Hons.) from the University of Manitoba and joined Genesys Venture Inc. in 2000. He oversees treasury and contract administration, supports fundraising for client companies, and has held executive roles at Miraculins and Kane Biotech.

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Digital Health ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path

DiaMedica Therapeuticsdiamedica.com in 𝕏NASDAQ: DMAC

DiaMedica Therapeutics develops therapies aimed at reducing ischemia in patients with serious vascular diseases, with an initial focus on preeclampsia, fetal growth restriction, and acute ischemic stroke.

BiotechDigital HealthMinneapolis, US

David J. Wambeke(Executive Officer)Lorianne Masuoka(Executive Officer)Rick Pauls(Executive Officer, Director)Scott Kellen(Executive Officer)Todd Verdoorn(Executive Officer)Paul Papi(Executive Officer)

Co-investorsShepherd Ventures

Exits · 1

IPOs and acquisitions across the tracked portfolio

DiaMedica TherapeuticsNASDAQ: DMAC

Portfolio news

latest coverage across their companies

DiaMedica Therapeutics (DMAC): BioTech with Breakthrough Potential

DiaMedica Therapeutics · finance.yahoo.com · Aug 3, 2026

Frequently asked questions

What stage does CentreStone Ventures invest at?: CentreStone Ventures invests at the Pre-Seed, Seed, Series A stages.
What is CentreStone Ventures's typical check size?: CentreStone Ventures typically writes checks of $182.5K – $1.8M.
What sectors does CentreStone Ventures focus on?: CentreStone Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is CentreStone Ventures located?: CentreStone Ventures is headquartered in Winnipeg, CA.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Innovestor Ventures

Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.

$270K – $3.2M

Khosla Ventures

Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.

$5K – $50M